Tina Sehm
Affiliations: | 2011- | Translational Cell Biology | Universitätsklinikum Erlangen |
Google:
"Tina Sehm"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Baecker J, Wartchow K, Sehm T, et al. (2019) Treatment with the Neurotrophic Protein S100B Increases Synaptogenesis Following Traumatic Brain Injury. Journal of Neurotrauma |
Galli R, Uckermann O, Sehm T, et al. (2019) Identification of distinctive features in human intracranial tumors by label-free nonlinear multimodal microscopy. Journal of Biophotonics. e201800465 |
Dahlmanns M, Yakubov E, Chen D, et al. (2017) Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Discovery. 3: 17030 |
Sehm T, Rauh M, Wiendieck K, et al. (2016) Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis. Oncotarget |
Ghoochani A, Hatipoglu Majernik G, Sehm T, et al. (2016) Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis. Oncotarget. 7: 38306-38318 |
Sehm T, Fan Z, Ghoochani A, et al. (2016) Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget |
Fan Z, Bittermann-Rummel P, Yakubov E, et al. (2016) PRG3 induces Ras-dependent oncogenic cooperation in gliomas. Oncotarget |
Ghoochani A, Yakubov E, Sehm T, et al. (2015) A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain. Oncotarget |
Hatipoglu G, Hock SW, Weiss R, et al. (2015) Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment. Cancer Science. 106: 160-70 |
Sehm T, Fan Z, Weiss R, et al. (2014) The impact of dietary isoflavonoids on malignant brain tumors. Cancer Medicine. 3: 865-77 |